This advert is not available!
Unit
The Center for Hematology and Regenerative medicine, HERM is a research unit within the Department of Medicine Huddinge with a focus on translational hematology and immunology. HERM is located in the NEO building and consists of a mix of clinical and preclinical research groups, each with a focus on clinically relevant questions in hematology, stem cell biology and immunology, including basic immunology, immunodeficiency and transfusion immunology.
Research groups
The candidate will work in the research group of Professor Petter Höglund, a translational immunology group working on natural killer (NK) cells, immune responses to platelet transfusions and blood transfusion practices in hematology patients. (https://ki.se/en/medh/petter-hoglund-group) The group is looking for a motivated, well-organized co-worker to serve as lab manager across the group’s various projects.
Responsibilities
The duties in the group are multifaceted. One aspect entail organisational and administrative tasks, keeping track on day-to-day routines, including daily support functions in the lab, administration associated with chemical and biological work, introduction of new members in the group, organization of group meetings and representation of the group within HERM when the group leader is not present. It is expected that the lab manager keeps track of funding possibilities for group members and assists the group leader in communication tasks both internally and with collaborators.
Laboratory work includes all aspects of an immunology lab, such as molecular biology, cell culture and flow cytometry. Advanced FACS experience, including cell sorting, is required and basic knowledge of bioinformatics tools an advantage. Experience from work with both mouse and human cells is necessary. Possibilities for conducting independent projects will be encouraged if time allows.
Qualifications and entry requirements
Applicants must have adequate university education in biomedicine or cell biology. Experience from research environments and from own research projects will be considered an advantage. The successful candidate is very well-organized, responsible and likes to work in a dynamic environment with diverse tasks. The candidate also takes pride in providing service to others. The applicant should have practical experience in standard molecular biology, cell biology and flow cytometry techniques. Good collaborate skills, independence, communication skills and computer skills re required. Knowledge using bioinformatics tools are considered advantageous. Knowledge of Karolinska Institutet's databases (ELN) and documented documentation skills will be asked for. Good knowledge in written and spoken English is required.
Application process
An employment application must contain the following documents in English:
What do we offer?
A creative and inspiring environment full of expertise and curiosity. Karolinska Institutet is one of the world's leading medical universities. Our vision is to pursue the development of knowledge about life and to promote a better health for all. At Karolinska Institutet, we conduct successful medical research and hold the largest range of medical education in Sweden. Karolinska Institutet is a state university, which entitles to several benefits such as extended holiday and generous occupational pension. Employees also have access to our modern gym for free and receive reimbursements for medical care.
Location: Flemingsberg
Application
Welcome to apply at the latest 2019-11-29
The application is to be submitted through the Varbi recruitment system.
Permanent position are initiated by a six months trial period.
Type of employment | Permanent position |
---|---|
Contract type | Full time |
First day of employment | According to agreement |
Salary | Monthly salary |
Number of positions | 1 |
Full-time equivalent | 100% |
City | Huddinge |
County | Stockholms län |
Country | Sweden |
Reference number | 2-5650/2019 |
Contact |
|
Union representative |
|
Published | 15.Nov.2019 |
Last application date | 29.Nov.2019 11:59 PM CET |